Astrocytomas and oligodendrogliomas were characterized by their typical histological features and, when required, further classified based on immunoreactivity against GFAP and Olig2 on >50% of neoplastic cells, respectively. This evidence concerns the gene GFAP and astrocytoma (excluding glioblastoma).